Observational studyFrontiers in endocrinology2026
Effect of Qingre Lishi decoction on anthropometric and metabolic risk indices in obese patients with newly diagnosed T2DM: a real-world observational study.
Observational study in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: We have found the Qingre Lishi decoction can effectively reduce blood glucose and mitigates glycemic fluctuations in patients with newly diagnosed type 2 diabetes mellitus (T2DM). However, its influence on body fat distribution and associated metabolic parameters remains underexplored. This study aims to provide more comprehensive and integrated evidence regarding the clinical efficacy of the Qingre Lishi decoction. Methods: We involved 70 overweight and obese patients with newly diagnosed T2DM between December 2021 and November 2022. Patients were allocated to the observation group ( Results: Regarding anthropometric indices, the observation group demonstrated significant reductions in WC, BMI, and WHtR, with the decreases in WC and WHtR being significantly greater than those in the control group ( Conclusion: The therapeutic efficacy of the Qingre Lishi decoction in overweight and obese patients with newly diagnosed T2DM is multifaceted, demonstrated by its ability to enhance abdominal fat distribution, lower TG and LDL-C levels, and improve metabolic risk indices (TyG, TyG-WC, TyG-BMI, and TyG-WHtR) for a more integrated patient outcome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.